Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 51

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 51
---
 or 
 will become exercisable within 60 days after such date.                                  |

| (2) | Shares owned by Dr. Parker are Ordinary                                                  
 Shares subject to outstanding stock options which are exercisable at December 1, 2025 or 
 will become exercisable within 60 days after such date.                                  |

| (3) | Shares owned by Mr. Stamp are Ordinary                                                   
 Shares subject to outstanding stock options which are exercisable at December 1, 2025 or 
 will become exercisable within 60 days after such date.                                  |

| (4) | Shares owned by Dr. Turton include                                                       
 14,400,000 Ordinary Shares subject to outstanding stock options which are exercisable at 
 December 1, 2025 or will become exercisable within 60 days after such date.              |

| (5) | Shares owned by Dr. de Vries are Ordinary                                                
 Shares subject to outstanding stock options which are exercisable at December 1, 2025 or 
 will become exercisable within 60 days after such date.                                  |

| (6) | Shares owned by all directors and                                                             
 senior management as a group include 109,632,375 Ordinary Shares subject to outstanding stock 
 options, which are exercisable at December 1, 2025 or will become exercisable within 60 days  
 after such date.                                                                              |

As
of December 1, 2025, approximately 0.0006% of our outstanding Ordinary Shares was held by registered shareholders with addresses in the
United Kingdom, and we had 185 holders of record in the United Kingdom (in each case, excluding shares held by the custodian under our
depositary agreement with JPMorgan Chase Bank, N.A.). As of December 1, 2025, JPMorgan Chase Bank, N.A., as depositary for the Depositary
Shares, held 67,885,252,427 Ordinary Shares, representing approximately 99.6% of the issued share capital held at that date. As of December
1, 2025, we had two holders of record with an address in the United States. The number of holders of record or registered holders in
the United States or United Kingdom is not representative of the number of beneficial holders or of the residence of beneficial holders.

Based on our share register,
we believe that we are not directly or indirectly controlled by another corporation or government, or by any other natural or legal persons.
There are no arrangements that may result